ILLUMINA, INC. Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)
ILLUMINA, INC. (ILMN) reported Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) of $23.00 million for the 12-month period ending 2025-12-28, per its 10-K filed 2026-02-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill · last filed 2026-02-12
- ILLUMINA, INC. impairment of intangible assets, indefinite-lived (excluding goodwill) for the quarter ending 2017-12-31 was $0.00.
- ILLUMINA, INC. impairment of intangible assets, indefinite-lived (excluding goodwill) for the quarter ending 2017-10-01 was $0.00.
- ILLUMINA, INC. impairment of intangible assets, indefinite-lived (excluding goodwill) for the quarter ending 2017-07-02 was $0.00.
- ILLUMINA, INC. impairment of intangible assets, indefinite-lived (excluding goodwill) for the quarter ending 2017-04-02 was $5.00M.
- ILLUMINA, INC. impairment of intangible assets, indefinite-lived (excluding goodwill) for fiscal 2025 was $23.00M.
- ILLUMINA, INC. impairment of intangible assets, indefinite-lived (excluding goodwill) for fiscal 2017 was $5.00M.
- ILLUMINA, INC. impairment of intangible assets, indefinite-lived (excluding goodwill) for fiscal 2012 was $21.44M.
| Period end | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 3 month | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 3 month as first filed | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 6 month | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 9 month | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 12 month |
|---|---|---|---|---|---|
| 2025-12-28 | $23.00M 10-K · filed 2026-02-12 | ||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-12 | $0.00 derived: sum of 2 quarters · filed 2019-02-12 | $0.00 derived: sum of 3 quarters · filed 2019-02-12 | $5.00M 10-K · filed 2019-02-12 | |
| 2017-10-01 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-24 | $0.00 derived: sum of 2 quarters · filed 2018-10-24 | $5.00M 10-Q · filed 2018-10-24 | ||
| 2017-07-02 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-31 | $5.00M 10-Q · filed 2018-07-31 | |||
| 2017-04-02 | $5.00M 10-Q · filed 2018-04-25 | ||||
| 2013-09-29 | $25.21M 10-Q · filed 2013-11-06 | ||||
| 2012-12-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-15 | $0.00 derived: sum of 2 quarters · filed 2013-11-06 | $21.40M derived: sum of 3 quarters · filed 2014-02-18 | $21.44M 10-K · filed 2013-02-15 | |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06 | $21.40M derived: sum of 2 quarters · filed 2014-02-18 | $21.44M 10-Q · filed 2013-11-06 | ||
| 2012-07-01 | $21.40M 10-K · filed 2014-02-18 | $21.44M 10-Q · filed 2012-07-30 | $21.44M 10-Q · filed 2013-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WATERS CORP /DE/ (WAT) | United States | $42.297B | 224.28 |
| AGILENT TECHNOLOGIES, INC. (A) | United States | $48.720B | 27.14 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |